Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: JAMA. 2014 Jun 25;311(24):2518–2531. doi: 10.1001/jama.2014.6634

Figure 2.

Figure 2

Adjusted hazard ratio of all-cause mortality by percent change in eGFR, its distribution, and corresponding percent population attributable risk during a 2-year baseline period in eGFR<60 ml/min/1.73m2 (A) and eGFR≥60 ml/min/1.73m2 (B). Values trimmed at <−70% change (0.30% and 0.050% of the study population in eGFR <60 and ≥60 ml/min/1.73m2, respectively) and >40% change (5.8% and 0.46% of the population in eGFR <60 and ≥60 ml/min/1.73m2, respectively).